Vise Technologies, Inc. Sanofi Transaction History

Vise Technologies, Inc.

$771 Million
Q3 2024

A detailed history of Vise Technologies, Inc. transactions in Sanofi stock. As of the latest transaction made, Vise Technologies, Inc. holds 24,730 shares of SNY stock, worth $1.19 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

24,730

Previous 21,169 16.82%

Holding current value

$1.19 Million

Previous $1.03 Million 38.75%

% of portfolio

0.18%

Previous 0.18%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$48.54 - $58.53 $172,850 - $208,425	3,561 Added 16.82%	24,730 $1.43 Million
Q2 2024 Aug 01, 2024	SELL	$45.39 - $50.36 $48,930 - $54,288	-1,078 Reduced 4.85%	21,169 $1.03 Million
Q1 2024 May 15, 2024	SELL	$45.75 - $52.48 $116,479 - $133,614	-2,546 Reduced 10.27%	22,247 $1.08 Million
Q4 2023 Feb 07, 2024	SELL	$43.13 - $54.79 $282,932 - $359,422	-6,560 Reduced 20.92%	24,793 $1.23 Million
Q3 2023 Oct 31, 2023	SELL	$50.95 - $55.2 $50,287 - $54,482	-987 Reduced 3.05%	31,353 $1.68 Million
Q2 2023 Aug 08, 2023	BUY	$50.45 - $57.18 $75,826 - $85,941	1,503 Added 4.87%	32,340 $1.74 Million
Q1 2023 May 10, 2023	BUY	$45.86 - $54.45 $151,200 - $179,521	3,297 Added 11.97%	30,837 $1.68 Million
Q4 2022 Feb 09, 2023	BUY	$38.86 - $48.55 $117,046 - $146,232	3,012 Added 12.28%	27,540 $1.33 Million
Q3 2022 Nov 14, 2022	BUY	$37.22 - $100.5 $130,530 - $352,453	3,507 Added 16.68%	24,528 $933,000
Q2 2022 Aug 15, 2022	BUY	$48.99 - $57.46 $408,723 - $479,388	8,343 Added 65.81%	21,021 $1.05 Million
Q1 2022 Jun 08, 2022	BUY	$48.48 - $53.65 $614,629 - $680,174	12,678 New	12,678 $651,000

Others Institutions Holding SNY

# of Institutions

820

Shares Held

274M

Call Options Held

Put Options Held

1.9M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $121B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vise Technologies, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vise Technologies, Inc. with notifications on news.

Account

Vise Technologies, Inc. Sanofi Transaction History